By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

arGentis Pharmaceuticals, LLC 

896 Stone Hedge Cove

Collierville  Tennessee  38017-7379  U.S.A.
Phone: 901-448-1580 Fax: n/a


SEARCH JOBS








Company News
arGentis Pharmaceuticals, LLC Acquires Rights to Rheumatoid Arthritis Therapy Entering Phase I Clinical Trial; Partnering with University of Tennessee And Veterans Affairs Medical Center 11/12/2009 9:25:08 AM
arGentis Pharmaceuticals, LLC Expands Scientific Advisory Board 10/16/2009 8:16:11 AM
arGentis Pharmaceuticals, LLC Receives Orphan Drug Designation for European Union 2/17/2009 9:50:57 AM
arGentis Pharmaceuticals, LLC Receives Favorable Opinion for European Orphan Drug Designation 1/6/2009 8:47:22 AM
arGentis Pharmaceuticals, LLC Presents at Southeast BIO (SEBIO) 10th Annual Investor Forum 12/10/2008 9:14:21 AM
arGentis Pharmaceuticals, LLC Files Patent on Nucleic Acid Sequences and Polymorphisms Predictive of Patient Responses to ARG201 an Immunotherapy for Late Phase Systemic Sclerosis 7/1/2008 10:24:46 AM
arGentis Pharmaceuticals, LLC Release: Phase II Results for Low-Dose Oral Immune Tolerance Therapy (ARG201) in Systemic Scleroderma Published 6/30/2008 9:13:18 AM
arGentis Pharmaceuticals, LLC Licenses Third Treatment for Dry Eye Syndrome 5/12/2008 10:24:21 AM
Innova Memphis Inc. Invests In arGentis Pharmaceuticals, LLC 4/21/2008 8:45:48 AM
arGentis Pharmaceuticals, LLC Receives Orphan Drug Designation 2/8/2008 7:49:21 AM
12
//-->